Reinhard Vogt brings a wealth of industry knowledge and technology deal-side expertise to Dynamk Capital. He is instrumental in differentiating Dynamk by providing portfolio companies valuable guidance in all areas of commercialization as well as positioning for exit. Prior to joining Dynamk, he was the Executive VP and Member of the Board of Sartorius Stedim Biotech S.A, a leading international partner to biotechnology and pharmaceutical companies, providing critical solutions for research, development and manufacturing. He was instrumental in building and transforming their filtration business from $30 million in the 90s, to what is now today the Sartorius Bioprocess Business of around $1.2 billion. He served as Executive VP and Member of the Board of Sartorius AG for over 10 years and has served as Director of 15 companies and Sartorius affiliates in his career.